Anzeige
Mehr »
Login
Dienstag, 07.05.2024 Börsentäglich über 12.000 News von 686 internationalen Medien
+56,25% in 5 Tagen: Genialer Schachzug - diese Übernahme verändert alles
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
15 Leser
Artikel bewerten:
(0)

Radiation Therapy Services Appoints New Chief Financial Officer


FORT MYERS, Fla., March 20 /PRNewswire-FirstCall/ -- Radiation Therapy Services, Inc. , a leading operator of radiation therapy centers, announced today that David N.T. Watson has been appointed chief financial officer to succeed David M. Koeninger, who announced his retirement last year. Mr. Watson will join the Company in early April and assume the role of chief financial officer effective July 1, 2007. Mr. Koeninger will remain chief financial officer and assist with the role transition through June 30, 2007 and remain with the Company on a consultant basis until June 2008.

Mr. Watson is currently Treasurer & Vice President, Finance for The GEO Group, Inc., a New York Stock Exchange-listed world leader in the delivery of correctional, detention and residential treatment services to federal, state, and local government agencies around the globe. In this role, he is responsible for all merger and acquisition activities, and treasury and tax management. He is also the primary contact for corporate banking, financing, debt investor and rating agency relationships. Mr. Watson has been with The GEO Group since 1994, in positions covering all areas of finance, including Chief Accounting Officer, Corporate Controller, Assistant Secretary, and Assistant Treasurer. Prior to joining The GEO Group, he held several positions at Arthur Andersen LLP, most recently as Manager, Audit and Business Advisory Services. Prior to joining Arthur Andersen, he was with Arthur Young & Co. Mr. Watson holds an MBA in accounting from Rutgers, The State University of New Jersey and a BA in economics from University of Virginia.

Dr. Daniel Dosoretz, President and Chief Executive Officer, said, "David Watson's strong public company finance experience and familiarity with the complexities of multi-site facility management make him an ideal candidate for our CFO position. In addition, I believe David Watson's experience communicating with the investment community will help ensure a smooth transition. We are very pleased to welcome him to the Company and are confident that he will be a valuable addition to the senior management team."

Dr. Dosoretz added, "On behalf of the Board of Directors and management, I'd like to thank David Koeninger for his dedicated service to the Company and wish him the best in his retirement."

About Radiation Therapy Services, Inc.

Radiation Therapy Services, Inc., which operates radiation treatment centers primarily under the name 21st Century Oncology, is a provider of radiation therapy services to cancer patients. The Company's 77 treatment centers are clustered into 25 local markets in 16 states, including Alabama, Arizona, California, Delaware, Florida, Kentucky, Maryland, Massachusetts, Michigan, Nevada, New Jersey, New York, North Carolina, Pennsylvania, Rhode Island and West Virginia. The Company is headquartered in Fort Myers, Florida. More information about the Company can be found at its Web site http://www.rtsx.com/. RTSXG

Contacts: Investors: Dave Koeninger Nick Laudico Chief Financial Officer The Ruth Group Radiation Therapy Services, Inc. 646-536-7030 239-931-7282nlaudico@theruthgroup.comdkoeninger@rtsx.com

Kupfer - Jetzt! So gelingt der Einstieg in den Rohstoff-Trend!
In diesem kostenfreien Report schaut sich Carsten Stork den Kupfer-Trend im Detail an und gibt konkrete Produkte zum Einstieg an die Hand.
Hier klicken
© 2007 PR Newswire
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.